FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3200976543> ?p ?o ?g. }

• W3200976543 endingPage "3667" @default.
• W3200976543 startingPage "3659" @default.
• W3200976543 abstract "Desmoid tumors (aggressive fibromatosis) are soft tissue mesenchymal tumors that can be locally invasive and life-threatening. Depending on the location, these tumors are often unresectable or tend to recur after surgery. To date, there are no approved systemic therapies for desmoid tumors. These tumors typically harbor mutations in the β-catenin oncogene CTNNB1 or the tumor suppressor gene adenomatous polyposis coli, resulting in constitutive activation of the WNT pathway. The Notch pathway is part of the underlying cause for desmoid tumor development, possibly due to crosstalk with the WNT pathway, providing a rationale for Notch inhibition as a therapeutic strategy. The gamma secretase activation of the Notch receptor can be targeted with investigational gamma secretase inhibitors. In this case report, we follow the course of 2 patients with desmoid tumors treated with the highly potent, parenterally administered investigational gamma secretase inhibitor AL101, resulting in long-lasting responses. Case 1 reports on a patient with a mesenteric desmoid tumor who participated in a phase 1 trial and then transitioned into a compassionate use program; Case 2 reports on a patient with recurrent pelvic tumors receiving AL101 through a compassionate use program. After tumor progression on other systemic therapies, Cases 1 and 2 had confirmed partial responses (41% and 60% maximal tumor size decrease from baseline) recorded after 1.0 and 1.6 years of treatment with AL101, with a duration of response of 8.6+ and 2.6+ years, respectively. Also, in a phase 1 study of AL102, a potent orally administered gamma secretase inhibitor that shares structural features with AL101, a patient with a desmoid tumor was noted to have tumor shrinkage. Formal clinical testing of AL102 for the treatment of patients with desmoid tumors that are not amenable to surgery or are refractory to/recurrent from other prior therapies is currently underway." @default.
• W3200976543 created "2021-09-27" @default.
• W3200976543 creator A5012241694 @default.
• W3200976543 creator A5049245990 @default.
• W3200976543 creator A5063382695 @default.
• W3200976543 creator A5078038970 @default.
• W3200976543 date "2021-09-21" @default.
• W3200976543 modified "2023-10-10" @default.
• W3200976543 title "Activity of the Gamma Secretase Inhibitor AL101 in Desmoid Tumors: A Case Report of 2 Adult Cases" @default.
• W3200976543 cites W1547479894 @default.
• W3200976543 cites W1970852339 @default.
• W3200976543 cites W2018526667 @default.
• W3200976543 cites W2039109621 @default.
• W3200976543 cites W2043275312 @default.
• W3200976543 cites W2046792469 @default.
• W3200976543 cites W2105613367 @default.
• W3200976543 cites W2109541355 @default.
• W3200976543 cites W2116318030 @default.
• W3200976543 cites W2126543235 @default.
• W3200976543 cites W2156790281 @default.
• W3200976543 cites W2597641129 @default.
• W3200976543 cites W2761733096 @default.
• W3200976543 cites W2771031544 @default.
• W3200976543 cites W2797850256 @default.
• W3200976543 cites W2890046006 @default.
• W3200976543 cites W2905567470 @default.
• W3200976543 cites W2946919661 @default.
• W3200976543 cites W2963740442 @default.
• W3200976543 cites W3004209283 @default.
• W3200976543 cites W3047830116 @default.
• W3200976543 cites W3087935245 @default.
• W3200976543 cites W3131100500 @default.
• W3200976543 cites W3135580999 @default.
• W3200976543 cites W598525099 @default.
• W3200976543 doi "https://doi.org/10.3390/curroncol28050312" @default.
• W3200976543 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8482204" @default.
• W3200976543 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34590610" @default.
• W3200976543 hasPublicationYear "2021" @default.
• W3200976543 type Work @default.
• W3200976543 sameAs 3200976543 @default.
• W3200976543 citedByCount "10" @default.
• W3200976543 countsByYear W32009765432022 @default.
• W3200976543 countsByYear W32009765432023 @default.
• W3200976543 crossrefType "journal-article" @default.
• W3200976543 hasAuthorship W3200976543A5012241694 @default.
• W3200976543 hasAuthorship W3200976543A5049245990 @default.
• W3200976543 hasAuthorship W3200976543A5063382695 @default.
• W3200976543 hasAuthorship W3200976543A5078038970 @default.
• W3200976543 hasBestOaLocation W32009765431 @default.
• W3200976543 hasConcept C121608353 @default.
• W3200976543 hasConcept C126322002 @default.
• W3200976543 hasConcept C137620995 @default.
• W3200976543 hasConcept C142724271 @default.
• W3200976543 hasConcept C143998085 @default.
• W3200976543 hasConcept C161879069 @default.
• W3200976543 hasConcept C170493617 @default.
• W3200976543 hasConcept C2775983998 @default.
• W3200976543 hasConcept C2777995640 @default.
• W3200976543 hasConcept C2778237340 @default.
• W3200976543 hasConcept C2779931649 @default.
• W3200976543 hasConcept C2780814781 @default.
• W3200976543 hasConcept C502942594 @default.
• W3200976543 hasConcept C526805850 @default.
• W3200976543 hasConcept C55493867 @default.
• W3200976543 hasConcept C62478195 @default.
• W3200976543 hasConcept C71924100 @default.
• W3200976543 hasConcept C86803240 @default.
• W3200976543 hasConceptScore W3200976543C121608353 @default.
• W3200976543 hasConceptScore W3200976543C126322002 @default.
• W3200976543 hasConceptScore W3200976543C137620995 @default.
• W3200976543 hasConceptScore W3200976543C142724271 @default.
• W3200976543 hasConceptScore W3200976543C143998085 @default.
• W3200976543 hasConceptScore W3200976543C161879069 @default.
• W3200976543 hasConceptScore W3200976543C170493617 @default.
• W3200976543 hasConceptScore W3200976543C2775983998 @default.
• W3200976543 hasConceptScore W3200976543C2777995640 @default.
• W3200976543 hasConceptScore W3200976543C2778237340 @default.
• W3200976543 hasConceptScore W3200976543C2779931649 @default.
• W3200976543 hasConceptScore W3200976543C2780814781 @default.
• W3200976543 hasConceptScore W3200976543C502942594 @default.
• W3200976543 hasConceptScore W3200976543C526805850 @default.
• W3200976543 hasConceptScore W3200976543C55493867 @default.
• W3200976543 hasConceptScore W3200976543C62478195 @default.
• W3200976543 hasConceptScore W3200976543C71924100 @default.
• W3200976543 hasConceptScore W3200976543C86803240 @default.
• W3200976543 hasIssue "5" @default.
• W3200976543 hasLocation W32009765431 @default.
• W3200976543 hasLocation W32009765432 @default.
• W3200976543 hasLocation W32009765433 @default.
• W3200976543 hasLocation W32009765434 @default.
• W3200976543 hasLocation W32009765435 @default.
• W3200976543 hasLocation W32009765436 @default.
• W3200976543 hasOpenAccess W3200976543 @default.
• W3200976543 hasPrimaryLocation W32009765431 @default.
• W3200976543 hasRelatedWork W2062150443 @default.
• W3200976543 hasRelatedWork W2091280055 @default.
• W3200976543 hasRelatedWork W2147162859 @default.
• W3200976543 hasRelatedWork W2437133654 @default.

• next